]), we examined the effects of precise amino acid substitution in this protein on resistance of viral replication to the cytokine. Only substitution of residues 443 to 448 of E1B for alanine (E1B Sub19) specifically impaired production of progeny virus and resulted in a large defect in viral DNA synthesis in IFN-treated normal human fibroblasts. Untreated or IFN-treated cells infected by this mutant virus (AdEasyE1Sub19) contained much higher steady-state concentrations of IFN-inducible GBP1 and IFIT2 mRNAs than did wild-typeinfected cells and of the corresponding newly transcribed pre-mRNAs, isolated exploiting 5=-ethynyluridine labeling and click chemistry. These results indicated that the mutations created by substitution of residues 443 to 448 for alanine (Sub19) impair repression of transcription of IFN-inducible genes, by the E1B, 55-kDa protein, consistent with their location in a segment required for repression of p53-dependent transcription. However, when synthesized alone, the E1B 55-kDa protein inhibited expression of the p53-regulated genes BAX and MDM2 but had no impact whatsoever on induction of IFIT2 and GBP1 expression by IFN. These observations correlate repression of transcription of IFN-inducible genes by the E1B 55-kDa protein with protection against inhibition of viral genome replication and indicate that the E1B 55-kDa protein is not sufficient to establish such transcriptional repression.T he E1B gene of species C human adenoviruses such as adenovirus type 5 (Ad5) encodes major, unrelated proteins of 19 and 55 kDa, each of which can cooperate with viral E1A gene products to transform rodent cells and counter host cell responses detrimental to viral replication (1, 2). The E1B 19-kDa protein is a viral homolog of cellular antiapoptotic proteins such as Bcl2 and blocks induction of apoptosis by the E1A proteins in transformed and infected cells (2, 3). The known protective functions of the E1B 55-kDa protein are fulfilled by a virus-specific E3 ubiquitin (Ub) ligase assembled from the E1B and the viral E4 Orf6 proteins and the cellular proteins cullin5, elongins B and C, and Rbx1 (4, 5), which ubiquitinylates multiple cellular substrates to target them for subsequent proteasomal degradation. These substrates include the cellular tumor suppressor p53 (4-7) and the Mre11, Rad50, and Nbs1 proteins, which comprise the MRN complex (8). As the viral immediate-early E1A 243R protein can induce apoptosis via stabilization of p53 (9-12), removal of the latter protein as a result of the action of the E1B 55-kDa protein-containing E3 Ub ligase is thought to prevent induction of G 1 arrest or apoptosis in infected cells (1, 2, 13). The proteins of the MRN complex recognize double-strand breaks in DNA to activate signaling pathways that result in repair by recombination or nonhomologous end joining (NHEJ) (14-17). It is well established that when MRN components are not targeted for degradation by the virus-specific E3 Ub ligase or relocalized by the viral E4 Orf3 protein (8, 18), viral DNA synthesis is i...